Prenetics Global Stock (NASDAQ:PRE)


Chart

Previous Close

$12.71

52W Range

$3.10 - $17.99

50D Avg

$13.36

200D Avg

$8.24

Market Cap

$175.45M

Avg Vol (3M)

$141.13K

Beta

0.35

Div Yield

-

PRE Company Profile


Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

HK

Employees

285

IPO Date

Jul 16, 2021

Website

PRE Performance


Peer Comparison


TickerCompany
OSUROraSure Technologies, Inc.
TLSITriSalus Life Sciences, Inc.
SGMOSangamo Therapeutics, Inc.
CDXSCodexis, Inc.
STIMNeuronetics, Inc.
PROFProfound Medical Corp.
TickerGate Footer Logo

Tickergate is an AI research agent that helps investors analyze companies, filings, and markets faster and smarter.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks